Denmark: CS Medica unveils plans for Q3 IPO and listing on Spotlight Stock Market

Cannasen Arthritis Gel

CS Medica, a Danish medico cannabis company developing, manufacturing, and commercialising over-the-counter (OTC) medical device products containing cannabinoids, is to launch an IPO, with shares to be listed on the Spotlight Stock Market in Q3 2021. The company, founded in 2011, has a current focus on cannabidiol for the treatment of psoriasis and arthritis. It has…

You must be a HMI Subscriber to view this content.

Subscribe Now »